AzTrials
AzTrials

Neck PainTDCSNCT06204627

TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain

A study testing TDCS, Recognize (hand) - Laterality and Landscape recognition in people with Neck Pain and Chronic Pain, run by University of Sao Paulo General Hospital at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Chronic neck pain leads to decreased quality of life and absenteeism at work, generating great personal and socio-economic impact. It has been shown that patients with chronic pain have late recognition of the laterality of the hand, which is related to the duration of symptoms and pain evoked by the execution of the… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Neck Pain, Chronic Pain
What is being tested?
TDCS, Recognize (hand) - Laterality and Landscape recognition
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
1 siteBrazil
Study dates
30 Sep 2023to 1 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • participants over 18 years old;
  • pain in the cervical region, lasting more than three months and with intensity greater than 40/100 on the visual analog scale

Who cannot join

  • history of seizures or epilepsy,
  • history of head trauma,
  • intracranial hypertension,
  • intracranial metal clip,
  • pregnant or breastfeeding women,
  • skin lesions at the current application site;
Show all 13Show fewer
  • changes in sensitivity and allergy in the electrode positioning region.
  • intermittent pain;
  • Cancer;
  • cardiac pacemaker;
  • severe spinal diseases, such as recent fractures or ankylosing spondylitis;
  • serious cardiorespiratory diseases;
  • participants who refuse to sign the Free and Informed Consent Form.

Trial locations and contacts

1 site in 1 country.

Clarice Tanaka contact

551126616867

cltanaka@usp.br

Brazil1 site, 1 recruiting
  • Universidade de São Paulo

    São Paulo, 05403-000

    Clarice Tanaka, PhD

    Recruiting

Other trials in Brazil

About this study

Official title: Effects of Transcranial Stimulation by Direct Current Associated With Laterality Trainnning in Patients With Chronic Neck Pain

Chronic neck pain leads to decreased quality of life and absenteeism at work, generating great personal and socio-economic impact. It has been shown that patients with chronic pain have late recognition of the laterality of the hand, which is related to the duration of symptoms and pain evoked by the execution of the movement. These findings suggest that chronic pain and the consequent disuse of certain motor functions may involve a reorganization of the cortical representation of the body scheme or motor planning.

Non-invasive neuromodulation, such as transcranial direct current stimulation (TDCS), allows modulating cortical excitability and promoting pain relief.

This study intends to verify the effects of the association of noninvasive brain stimulation with TDCS with an intervention with visual and motor stimuli related to laterality in patients with neck pain.

Read the detailed description

The study will be controlled, randomized, double-blind and will include patients with chronic neck pain, divided into four groups:

  1. active TDCS associated with laterality recognition stimuli (n = 25);
  2. active TDCS associated with landscape recognition stimuli (n = 25);
  3. TDCS sham associated with laterality recognition stimuli (n = 25);
  4. TDCS sham associated with landscape recognition stimuli (n = 25);

Eight induction sessions will be held twice a week for four weeks. Patients who present a positive response in the first reassessment (responders) will remain in the study follow-up and will undergo a weekly maintenance session, for four weeks, and two more biweekly sessions.

The following instruments will be used for evaluation: motor safety thresholds through a MagVenture pulse generator with a flat surface coil, figure 8; OPAL, device with sensors; Recognize™ application; Visual Analog Scale (VAS); Brief Pain Inventory (BDI); Clinical Global Impression - ICG (patient and evaluated version); Pain McGill Standard Questionnaire - Short Format; Hospital Anxiety and Depression Scale (HAD); 36-item summary health survey from the Medical Outcomes Study (SF-36); Mini best test; neurodynamic tests (upper limb tension tests); and quantitative sensory tests. In addition to the pre- and post-intervention assessments, there will be post-treatment follow-up performed three, six and 12 months after randomization by telephone or e-mail. It is expected that the combined application of tDCS with stimuli related to laterality will have positive effects in patients with neck pain, impacting on variables such as pain, functional movements and quality of life of these patients.

Being tested
TDCS, Recognize (hand) - Laterality, Sham TDCS, Landscape recognition
Keywords
chronic pain, neck pain, functional laterality, transcranial direct current stimulation
Medical subject headings
Neck Pain, Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TDCSDevice

    Technique of non-invasive brain stimulation by direct current (TDCS) which involves the modulation of excitability and brain activity, capable of promoting reorganization of the cortical representation of the body schema or motor planning, and consequently, pain relief.

  • Recognize (hand) - LateralityDevice

    This technique stimulates the ability to recognize hand images as right/left quicklPatients with chronic pain present delayed recognition of hand laterality, which is related to the duration of symptoms and the pain evoked by the execution of the movement. Thus, this technique can have beneficial effects in breaking the pain.

  • Sham TDCSOther

    TDCS sham: The device remains inactive for 20 minutes.

  • Landscape recognitionOther

    Image recognition training that does not refer to right/left discrimination.

Study groups in NCT06204627
Study groupRoleWhat they receive
Active bipolar TDCS associated with laterality recognition stimuliActive comparatorParticipants will have carbon electrodes positioned, with contact through a 5x7cm sponge moistened in saline solution, with the anode on M1 and the cathode in the supra-orbital region. Individuals with active bipolar TDCS will receive a 2mA stimulus for twenty minutes. Meanwhile, they will use the Regognise hand application to discriminate right/left side of hand images.
Receives: Device: TDCS; Device: Recognize (hand) - Laterality
Active bipolar TDCS associated with landscape recognition stimuliActive comparatorParticipants will have carbon electrodes positioned, with contact through a 5x7cm sponge moistened in saline solution, with the anode on M1 and the cathode in the supra-orbital region. Individuals with active bipolar TDCS will receive a 2mA stimulus for twenty minutes. At the same time, they will be guided to recognize landscapes that do not refer to the recognition of laterality.
Receives: Device: TDCS; Other: Landscape recognition
Sham TDCS associated with laterality recognition stimuliActive comparatorParticipants will have carbon electrodes positioned, with contact through a 5x7cm sponge moistened in saline solution, with the anode on M1 and the cathode in the supra-orbital region. Stimulation will remain inactive for the 20 minutes. Meanwhile, they will use the Regognise hand app to discriminate right/left hand images.
Receives: Device: Recognize (hand) - Laterality; Other: Sham TDCS
Sham TDCS associated with landscape recognition stimuliPlacebo comparatorParticipants will have carbon electrodes positioned, with contact through a 5x7cm sponge moistened in saline solution, with the anode on M1 and the cathode in the supra-orbital region. Stimulation will remain inactive for the 20 minutes. At the same time, they will be guided to recognize landscapes that do not refer to the recognition of laterality.
Receives: Other: Sham TDCS; Other: Landscape recognition

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain symptoms

    Change from Baseline in pain symptoms on the Visual Scale after treatment

    Measured: up to 3 months

Secondary outcomes (1)
  1. Clinical Global Impression

    Change from Baseline in pain severity on the Clinical Global Impression scale after treatment

    Measured: up to 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2024
  2. Study start30 Sep 2023
  3. Primary completion30 Aug 2024 (estimated)
  4. Study completion1 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
The study will be controlled, randomized, double-blind and will include patients with chronic neck pain, divided into four groups: 1. active TDCS associated with laterality recognition stimuli (n = 25); 2. active TDCS associated with landscape recognition stimuli (n = 25); 3. TDCS sham associated with laterality recognition stimuli (n = 25); 4. TDCS sham associated with landscape recognition stimuli (n = 25).
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06204627
Sponsor's protocol ID
94350518.6.0000.0068
Acronym
TDCS
Status last verified
May 2024
First submitted
27 Aug 2020
Last updated
16 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing TDCS, Recognize (hand) - Laterality and Landscape recognition in people with Neck Pain and Chronic Pain, run by University of Sao Paulo General Hospital at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Clarice Tanaka (551126616867, cltanaka@usp.br), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain symptoms (time frame: up to 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in